Literature DB >> 21205737

The search for unaffected individuals with Lynch syndrome: do the ends justify the means?

Heather Hampel1, Albert de la Chapelle.   

Abstract

Lynch syndrome is the most common cause of inherited colorectal and endometrial cancers yet it is underrecognized in clinical practice. The relative merits of screening for Lynch syndrome among healthy adults without cancer versus among adults with colorectal or endometrial cancer are discussed in this Perspective article. Newly diagnosed colorectal cancer patients are a much easier target population for screening and this approach leads to more informative genetic test results, at a lower cost in most cases. ©2011 AACR.

Entities:  

Mesh:

Year:  2011        PMID: 21205737      PMCID: PMC3076593          DOI: 10.1158/1940-6207.CAPR-10-0345

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  19 in total

1.  The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC).

Authors:  H F Vasen; J P Mecklin; P M Khan; H T Lynch
Journal:  Dis Colon Rectum       Date:  1991-05       Impact factor: 4.585

2.  Feasibility of screening for Lynch syndrome among patients with colorectal cancer.

Authors:  Heather Hampel; Wendy L Frankel; Edward Martin; Mark Arnold; Karamjit Khanduja; Philip Kuebler; Mark Clendenning; Kaisa Sotamaa; Thomas Prior; Judith A Westman; Jenny Panescu; Dan Fix; Janet Lockman; Jennifer LaJeunesse; Ilene Comeras; Albert de la Chapelle
Journal:  J Clin Oncol       Date:  2008-09-22       Impact factor: 44.544

3.  Systematic review: family history in risk assessment for common diseases.

Authors:  Brenda J Wilson; Nadeem Qureshi; Pasqualina Santaguida; Julian Little; June C Carroll; Judith Allanson; Parminder Raina
Journal:  Ann Intern Med       Date:  2009-12-15       Impact factor: 25.391

4.  Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population.

Authors:  Tuan A Dinh; Benjamin I Rosner; James C Atwood; C Richard Boland; Sapna Syngal; Hans F A Vasen; Stephen B Gruber; Randall W Burt
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-18

Review 5.  Clinical utility of cancer family history collection in primary care.

Authors:  Brenda Wilson; Nadeem Qureshi; Julian Little; Pasqualina Santaguida; June Carroll; Judith Allanson; Homa Keshavarz; Parminder Raina
Journal:  Evid Rep Technol Assess (Full Rep)       Date:  2009-04

6.  Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members.

Authors:  Heikki J Järvinen; Laura Renkonen-Sinisalo; Katja Aktán-Collán; Päivi Peltomäki; Lauri A Aaltonen; Jukka-Pekka Mecklin
Journal:  J Clin Oncol       Date:  2009-08-31       Impact factor: 44.544

Review 7.  The current state of cancer family history collection tools in primary care: a systematic review.

Authors:  Nadeem Qureshi; June C Carroll; Brenda Wilson; Pasqualina Santaguida; Judith Allanson; Melissa Brouwers; Parminder Raina
Journal:  Genet Med       Date:  2009-07       Impact factor: 8.822

8.  Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives.

Authors: 
Journal:  Genet Med       Date:  2009-01       Impact factor: 8.822

9.  Family history-taking in community family practice: implications for genetic screening.

Authors:  L S Acheson; G L Wiesner; S J Zyzanski; M A Goodwin; K C Stange
Journal:  Genet Med       Date:  2000 May-Jun       Impact factor: 8.822

10.  The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer.

Authors:  Mercy Mvundura; Scott D Grosse; Heather Hampel; Glenn E Palomaki
Journal:  Genet Med       Date:  2010-02       Impact factor: 8.822

View more
  61 in total

1.  Determining the frequency of de novo germline mutations in DNA mismatch repair genes.

Authors:  Aung Ko Win; Mark A Jenkins; Daniel D Buchanan; Mark Clendenning; Joanne P Young; Graham G Giles; Jack Goldblatt; Barbara A Leggett; John L Hopper; Stephen N Thibodeau; Noralane M Lindor
Journal:  J Med Genet       Date:  2011-06-02       Impact factor: 6.318

2.  Lower prevalence of Lynch syndrome in colorectal cancer patients in a Japanese hospital-based population.

Authors:  Kensuke Kumamoto; Hideyuki Ishida; Okihide Suzuki; Yusuke Tajima; Noriyasu Chika; Koki Kuwabara; Keiichiro Ishibashi; Katsuharu Saito; Koji Nagata; Hidetaka Eguchi; Junichi Tamaru; Takeo Iwama
Journal:  Surg Today       Date:  2015-08-07       Impact factor: 2.549

3.  Moving the Needle on Action Around Evidence-Based Screening for Hereditary Conditions: Preparing State Chronic Disease Directors to Advance Precision Public Health.

Authors:  Amy Ponte; Samantha Greenberg; Karen Greendale; Laura Senier
Journal:  Public Health Rep       Date:  2019-03-21       Impact factor: 2.792

Review 4.  Public health action in genomics is now needed beyond newborn screening.

Authors:  M S Bowen; K Kolor; W D Dotson; R M Ned; M J Khoury
Journal:  Public Health Genomics       Date:  2012-09-11       Impact factor: 2.000

5.  Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps.

Authors:  Matthew B Yurgelun; Ajay Goel; Jason L Hornick; Ananda Sen; Danielle Kim Turgeon; Mack T Ruffin; Norman E Marcon; John A Baron; Robert S Bresalier; Sapna Syngal; Dean E Brenner; C Richard Boland; Elena M Stoffel
Journal:  Cancer Prev Res (Phila)       Date:  2012-01-18

6.  Actionable, pathogenic incidental findings in 1,000 participants' exomes.

Authors:  Michael O Dorschner; Laura M Amendola; Emily H Turner; Peggy D Robertson; Brian H Shirts; Carlos J Gallego; Robin L Bennett; Kelly L Jones; Mari J Tokita; James T Bennett; Jerry H Kim; Elisabeth A Rosenthal; Daniel S Kim; Holly K Tabor; Michael J Bamshad; Arno G Motulsky; C Ronald Scott; Colin C Pritchard; Tom Walsh; Wylie Burke; Wendy H Raskind; Peter Byers; Fuki M Hisama; Deborah A Nickerson; Gail P Jarvik
Journal:  Am J Hum Genet       Date:  2013-09-19       Impact factor: 11.025

Review 7.  Lynch syndrome: the patients' perspective.

Authors:  Jurgen Seppen; Linda Bruzzone
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

8.  Female Hormonal Factors and the Risk of Endometrial Cancer in Lynch Syndrome.

Authors:  Seyedeh Ghazaleh Dashti; Rowena Chau; Driss Ait Ouakrim; Daniel D Buchanan; Mark Clendenning; Joanne P Young; Ingrid M Winship; Julie Arnold; Dennis J Ahnen; Robert W Haile; Graham Casey; Steven Gallinger; Stephen N Thibodeau; Noralane M Lindor; Loïc Le Marchand; Polly A Newcomb; John D Potter; John A Baron; John L Hopper; Mark A Jenkins; Aung Ko Win
Journal:  JAMA       Date:  2015-07-07       Impact factor: 56.272

Review 9.  Management of genetic syndromes predisposing to gynecologic cancers.

Authors:  Susan Miesfeldt; Amanda Lamb; Christine Duarte
Journal:  Curr Treat Options Oncol       Date:  2013-03

Review 10.  100 years Lynch syndrome: what have we learned about psychosocial issues?

Authors:  Eveline M A Bleiker; Mary Jane Esplen; Bettina Meiser; Helle Vendel Petersen; Andrea Farkas Patenaude
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.